The #ScheieEyeInstitute in MOTION mobile eye clinic brings advanced #EyeCare directly to #Philadelphia communities. As we combine state-of-the-art diagnostics, #TeleOphthalmology, and specialist expertise, we work to close gaps in screening, diagnosis, treatment, & #HealthEquity.
Scheie faculty member Lucie Guo, MD, PhD’s perspective, “Toward Autonomous Science with Agentic Artificial Intelligence,” was recently published in Cell. Congratulations! Please read Dr. Guo’s perspective at the provided QR code.
#Cell#AI#Science#ScheieEye#Perspectives
Sudden vision loss? A clinical trial may be available. Madhura Tamhankar, MD, is the PI for the Phase 3 NAION-301 trial at #ScheieEye. Patients must be evaluated within 14 days of symptom onset. See flyer for details/contact info. #Ophthalmology#VisionLoss#NAION#ClinicalTrial
AI researchers/engineers: Lama Al-Aswad, MD, MPH, & the OPTIC Lab invite you to enter the CLEAR-EC Grand Challenge & develop algorithms to optimize corneal endothelial cell evaluation for transplantation. Register: https://t.co/MGhoCIwZf9 #Ophthalmology#MachineLearning#Research
Congratulations to Jean Bennett, Katherine A. High and Albert Maguire, winners of the 2026 Breakthrough Prize in Life Sciences, for developing a therapy for inherited retinal degeneration that became the first FDA-approved gene therapy for a genetic disease. https://t.co/awmRtAX5vT
@Penn@ChildrensPhila@RockefellerUniv
Major milestone for genomic medicine: Penn’s Jean Bennett and Albert Maguire, with @childrensphila's Katherine High, have received the @Breakthrough Prize in Life Sciences for their pioneering work treating inherited blindness. https://t.co/k2fKGC9utC
Congratulations to Jean Bennett, Albert Maguire (@ScheieEye) & Katherine High (@ChildrensPhila), recipients of the 2026 @brkthroughprize in Life Sciences in recognition of their pioneering work developing gene therapy for inherited blindness! https://t.co/u5TiwWYU1I
Jean Bennett and Albert Maguire, creators of the first approved gene therapy for blindness, have been awarded Breakthrough prize for life sciences.
Read more about Bennett and Maguire at: https://t.co/iIxrsoWP5x
Please save the date for this CME Symposium with @VindicoMedEd, "Capitalizing on Advances in Thyroid Eye Disease (TED) Treatment." Our own Madhura Tamhankar, MD, who serves as Activity Chair for the North American Neuro-Ophthalmology Society, will be featured. #ThyroidEyeDisease
Madhura Tamhankar, MD, was elected to the Academy of Master Clinicians at Penn Medicine. Dr. Tamhankar is celebrated as a clinician exemplifying the Academy's highest standards of professionalism, humanism, and excellence in medicine.
#ClinicianExcellence#Ophthalmology
Scheie Eye Institute ophthalmologists have proudly volunteered with Puentes de Salud, a nonprofit health organization, for longer than a decade. Please read on to learn more about our community’s past and present partnership. @PuentesDeSalud#ScheieEye#Ophthalmology#Volunteer
Congratulations to Qi N. Cui, MD, PhD (@CuiLab) for receiving a prestigious Research to Prevent Blindness (@RPB_org) Career Advancement Award! We are very proud of your commitment to vision research.
Learn more about RPB grants: https://t.co/vupjFpP1fW
#Ophthalmology#Research
As we prepare to celebrate the 2025-2026 Scheie Staff Service Excellence Awardees, please join us in celebrating the 2024-2025 awardees! Additionally, congratulations to all of the incredible staff members celebrating career milestones and anniversaries!
#staffappreciation
The Department of Ophthalmology and the Scheie Eye Institute are charting an exciting course of growth, as evidenced by its expanding geographic footprint spanning multiple new locations across both Pennsylvania and New Jersey.
#Ophthalmology#Expansion#ScheieEyeInstitute